Revolutionizing Drug Discovery with NANOSTACKS™ Organ Models

High-complexity in vitro models for  drug development

CellStacks_logo final.png__PID:7254133e-e70b-4817-9c70-05409c9a9693

Our Services

Enhance your drug discovery with our cutting-edge in-vitro human relevant models

liver icon.svg__PID:4d528045-83ed-40f6-81f6-e24c71426bd9

Hepatotoxicity and ADME services

brain model icons.png__PID:8195c4bd-2d6d-4dcd-a21a-721d2f2f8032

Neurotoxicity services

liver and brain connectedicon.png__PID:10e996fb-c3f4-4873-a73c-6caee6bc4431

Multiorgan toxicity services 

Our Technology 

CellStacks_logo final.png__PID:7254133e-e70b-4817-9c70-05409c9a9693

NANOSTACKS™ technology: advancing research through in-vivo relevant organ models

Nanostacks images .png__PID:734e3595-7a52-4721-b200-04204f82c3b1

Explore NANOSTACKSTM, a cell culture platform designed for the development of high-complexity in vitro models. The use of NANOSTACKSTM-based models ensures the in vivo-relevancy of data from in vitro toxicity and efficacy studies, improving the success rate of drug development pipelines.

Trusted by

keel univrsirty.png__PID:440ad913-f0c1-48c2-b259-03d52448ec5d
university of ferrara .png__PID:5187bf7f-e3e4-42d6-88ba-b0e36b905be3
shefield university logo.jpg__PID:87078b4e-7dec-43bf-939f-ec64f704440a

The latest blogs

High-complexity in vitro models for the toxicity assessment of antibody-drug conjugates

High-complexity in vitro models for the toxicity assessment of antibody-drug conjugates

Antibody-drug conjugates (ADCs) target cancer cells while reducing harm to healthy tissue. However, off-target toxicity remains a concern, demanding thorough evaluation. Read this blog post to explore the role of advanced in vitro models for toxicity screening of ADCs.

Read More
5 tips for making your own complex in vitro model

5 tips for making your own complex in vitro model

Discover 5 essential tips for designing and setting up a complex in vitro model (CIVM) that mimics the human body more effectively than traditional models. From maximizing cell types to validating your model, these insights will help you advance your research and increase its relevance

Read More
Human Organs-on-Chips: easier said than done

Human Organs-on-Chips: easier said than done

Discover the current state of the art in organ-on-a-chip technologies and how they compare to conventional cell culture methods. Dr. Valon Llabjani, Founder and CEO of Revivocell Limited, explores the advancements, limitations, and the need for improved models. Learn about Revivocell's CELLBLOKS® technology, a modular multi-organ/cell type co-culture system that bridges the gap between traditional methods and organs-on-a-chip approaches.

Read More

Need some help?

If you're interested in discovering how  our organ models can benefit your research, we invite you to get in touch with us. Our team is available to provide further insights and address any inquiries you may have.

Contact information


Daresbury Laboratory, Sci-Tech Daresbury, Keckwick Lane Daresbury, Cheshire, WA4 4AD



BioLabs@NYU LANGONE, 180 Varick St, Floor 6, New York, NY 10014

Revivocell Brands

NANOSTACKS stip white.png__PID:23bff30e-eca7-4125-9868-6ac89c7cf352 registered trademark. white png.png__PID:71578730-e4eb-4f50-852a-7c721b84f60e